These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34884918)

  • 41. Astrocytic engagement of the corticostriatal synaptic cleft is disrupted in a mouse model of Huntington's disease.
    Villanueva CB; Stephensen HJT; Mokso R; Benraiss A; Sporring J; Goldman SA
    Proc Natl Acad Sci U S A; 2023 Jun; 120(24):e2210719120. PubMed ID: 37279261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bidirectional control of postsynaptic density-95 (PSD-95) clustering by Huntingtin.
    Parsons MP; Kang R; Buren C; Dau A; Southwell AL; Doty CN; Sanders SS; Hayden MR; Raymond LA
    J Biol Chem; 2014 Feb; 289(6):3518-28. PubMed ID: 24347167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posttranslational Modifications Regulate the Postsynaptic Localization of PSD-95.
    Vallejo D; Codocedo JF; Inestrosa NC
    Mol Neurobiol; 2017 Apr; 54(3):1759-1776. PubMed ID: 26884267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling.
    Torres-Peraza JF; Giralt A; García-Martínez JM; Pedrosa E; Canals JM; Alberch J
    Neurobiol Dis; 2008 Mar; 29(3):409-21. PubMed ID: 18063376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice.
    Stack EC; Dedeoglu A; Smith KM; Cormier K; Kubilus JK; Bogdanov M; Matson WR; Yang L; Jenkins BG; Luthi-Carter R; Kowall NW; Hersch SM; Beal MF; Ferrante RJ
    J Neurosci; 2007 Nov; 27(47):12908-15. PubMed ID: 18032664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
    Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
    J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
    Raymond LA; André VM; Cepeda C; Gladding CM; Milnerwood AJ; Levine MS
    Neuroscience; 2011 Dec; 198():252-73. PubMed ID: 21907762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
    Barry J; Akopian G; Cepeda C; Levine MS
    J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive Mitochondrial Dysfunction of Striatal Synapses in R6/2 Mouse Model of Huntington's Disease.
    Petersen MH; Willert CW; Andersen JV; Madsen M; Waagepetersen HS; Skotte NH; Nørremølle A
    J Huntingtons Dis; 2022; 11(2):121-140. PubMed ID: 35311711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.
    Fan J; Cowan CM; Zhang LY; Hayden MR; Raymond LA
    J Neurosci; 2009 Sep; 29(35):10928-38. PubMed ID: 19726651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein changes in synaptosomes of Huntington's disease knock-in mice are dependent on age and brain region.
    Sapp E; Seeley C; Iuliano M; Weisman E; Vodicka P; DiFiglia M; Kegel-Gleason KB
    Neurobiol Dis; 2020 Jul; 141():104950. PubMed ID: 32439598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HSF1, Aging, and Neurodegeneration.
    Liu AY; Minetti CA; Remeta DP; Breslauer KJ; Chen KY
    Adv Exp Med Biol; 2023; 1409():23-49. PubMed ID: 35995906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired Replenishment of Cortico-Striatal Synaptic Glutamate in Huntington's Disease Mouse Model.
    Buren C; Tu G; Raymond LA
    J Huntingtons Dis; 2020; 9(2):149-161. PubMed ID: 32310183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease.
    Singh BK; Vatsa N; Nelson VK; Kumar V; Kumar SS; Mandal SC; Pal M; Jana NR
    Mol Neurobiol; 2018 Aug; 55(8):6337-6346. PubMed ID: 29294248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RPS23RG1 Is Required for Synaptic Integrity and Rescues Alzheimer's Disease-Associated Cognitive Deficits.
    Zhao D; Meng J; Zhao Y; Huo Y; Liu Y; Zheng N; Zhang M; Gao Y; Chen Z; Sun H; Wang X; Jing C; Zhang T; Zhang X; Luo H; Wang X; Zhang J; Liu FR; Li Y; Bu G; Wen L; Huang TY; Xu H; Zhang YW
    Biol Psychiatry; 2019 Aug; 86(3):171-184. PubMed ID: 30292394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.
    Naydenov AV; Sepers MD; Swinney K; Raymond LA; Palmiter RD; Stella N
    Neurobiol Dis; 2014 Nov; 71():140-50. PubMed ID: 25134728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single Synapse Indicators of Impaired Glutamate Clearance Derived from Fast iGlu
    Dvorzhak A; Helassa N; Török K; Schmitz D; Grantyn R
    J Neurosci; 2019 May; 39(20):3970-3982. PubMed ID: 30819797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.
    Franich NR; Basso M; André EA; Ochaba J; Kumar A; Thein S; Fote G; Kachemov M; Lau AL; Yeung SY; Osmand A; Zeitlin SO; Ratan RR; Thompson LM; Steffan JS
    J Huntingtons Dis; 2018; 7(2):137-150. PubMed ID: 29843246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.